FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2565985037> ?p ?o ?g. }

• W2565985037 endingPage "80" @default.
• W2565985037 startingPage "75" @default.
• W2565985037 abstract "<h3>Aims</h3> To describe baseline characteristics and visual outcome for eyes treated with ranibizumab for diabetic macular oedema (DMO) from a multicentre database. <h3>Methods</h3> Structured clinical data were anonymised and extracted from an electronic medical record from 19 participating UK centres: age at first injection, ETDRS visual acuity (VA), number of injections, ETDRS diabetic retinopathy (DR) and maculopathy grade at baseline and visits. The main outcomes were change in mean VA from baseline, number of injections and clinic visits and characteristics affecting VA change and DR grade. <h3>Results</h3> Data from 12 989 clinic visits was collated from baseline and follow-up for 3103 eyes. Mean age at first treatment was 66 years. Mean VA (letters) for eyes followed at least 2 years was 51.1 (SD=19.3) at baseline, 54.2 (SD: 18.6) and 52.5 (SD: 19.4) at 1 and 2 years, respectively. Mean visual gain was five letters. The proportion of eyes with VA of 72 letters or better was 25% (baseline) and 33% (1 year) for treatment naïve eyes. Eyes followed for at least 6 months received a mean of 3.3 injections over a mean of 6.9 outpatient visits in 1 year. <h3>Conclusions</h3> In a large cohort of eyes with DMO treated with ranibizumab injections in the UK, 33% of patients achieved better than or equal to 6/12 in the treated eye at 12 months compared with 25% at baseline. The mean visual gain was five letters. Eyes with excellent VA at baseline maintain good vision at 18 months." @default.
• W2565985037 created "2017-01-06" @default.
• W2565985037 creator A5002791602 @default.
• W2565985037 creator A5006658362 @default.
• W2565985037 creator A5007816848 @default.
• W2565985037 creator A5010674928 @default.
• W2565985037 creator A5012964371 @default.
• W2565985037 creator A5013093721 @default.
• W2565985037 creator A5016588157 @default.
• W2565985037 creator A5019521414 @default.
• W2565985037 creator A5020223344 @default.
• W2565985037 creator A5023491214 @default.
• W2565985037 creator A5023564113 @default.
• W2565985037 creator A5024950645 @default.
• W2565985037 creator A5029283104 @default.
• W2565985037 creator A5035946370 @default.
• W2565985037 creator A5046543735 @default.
• W2565985037 creator A5046991800 @default.
• W2565985037 creator A5053694130 @default.
• W2565985037 creator A5054023024 @default.
• W2565985037 creator A5062927042 @default.
• W2565985037 creator A5068546316 @default.
• W2565985037 creator A5074056939 @default.
• W2565985037 creator A5080436954 @default.
• W2565985037 creator A5083522033 @default.
• W2565985037 creator A5084863264 @default.
• W2565985037 creator A5088003995 @default.
• W2565985037 creator A5091261500 @default.
• W2565985037 date "2016-12-13" @default.
• W2565985037 modified "2023-09-26" @default.
• W2565985037 title "The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group, Report 1: baseline characteristics and visual acuity outcomes in eyes treated with intravitreal injections of ranibizumab for diabetic macular oedema" @default.
• W2565985037 cites W1492470838 @default.
• W2565985037 cites W1547832571 @default.
• W2565985037 cites W1782108791 @default.
• W2565985037 cites W1786299986 @default.
• W2565985037 cites W1851610358 @default.
• W2565985037 cites W1970269110 @default.
• W2565985037 cites W1977644809 @default.
• W2565985037 cites W1980342089 @default.
• W2565985037 cites W1982179488 @default.
• W2565985037 cites W2006652444 @default.
• W2565985037 cites W2019246598 @default.
• W2565985037 cites W2022886290 @default.
• W2565985037 cites W2146660508 @default.
• W2565985037 cites W2162309497 @default.
• W2565985037 cites W2165446988 @default.
• W2565985037 cites W2177844192 @default.
• W2565985037 cites W2405700876 @default.
• W2565985037 cites W2425861222 @default.
• W2565985037 cites W2518713733 @default.
• W2565985037 cites W2616361514 @default.
• W2565985037 doi "https://doi.org/10.1136/bjophthalmol-2016-309313" @default.
• W2565985037 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27965262" @default.
• W2565985037 hasPublicationYear "2016" @default.
• W2565985037 type Work @default.
• W2565985037 sameAs 2565985037 @default.
• W2565985037 citedByCount "50" @default.
• W2565985037 countsByYear W25659850372017 @default.
• W2565985037 countsByYear W25659850372018 @default.
• W2565985037 countsByYear W25659850372019 @default.
• W2565985037 countsByYear W25659850372020 @default.
• W2565985037 countsByYear W25659850372021 @default.
• W2565985037 countsByYear W25659850372022 @default.
• W2565985037 countsByYear W25659850372023 @default.
• W2565985037 crossrefType "journal-article" @default.
• W2565985037 hasAuthorship W2565985037A5002791602 @default.
• W2565985037 hasAuthorship W2565985037A5006658362 @default.
• W2565985037 hasAuthorship W2565985037A5007816848 @default.
• W2565985037 hasAuthorship W2565985037A5010674928 @default.
• W2565985037 hasAuthorship W2565985037A5012964371 @default.
• W2565985037 hasAuthorship W2565985037A5013093721 @default.
• W2565985037 hasAuthorship W2565985037A5016588157 @default.
• W2565985037 hasAuthorship W2565985037A5019521414 @default.
• W2565985037 hasAuthorship W2565985037A5020223344 @default.
• W2565985037 hasAuthorship W2565985037A5023491214 @default.
• W2565985037 hasAuthorship W2565985037A5023564113 @default.
• W2565985037 hasAuthorship W2565985037A5024950645 @default.
• W2565985037 hasAuthorship W2565985037A5029283104 @default.
• W2565985037 hasAuthorship W2565985037A5035946370 @default.
• W2565985037 hasAuthorship W2565985037A5046543735 @default.
• W2565985037 hasAuthorship W2565985037A5046991800 @default.
• W2565985037 hasAuthorship W2565985037A5053694130 @default.
• W2565985037 hasAuthorship W2565985037A5054023024 @default.
• W2565985037 hasAuthorship W2565985037A5062927042 @default.
• W2565985037 hasAuthorship W2565985037A5068546316 @default.
• W2565985037 hasAuthorship W2565985037A5074056939 @default.
• W2565985037 hasAuthorship W2565985037A5080436954 @default.
• W2565985037 hasAuthorship W2565985037A5083522033 @default.
• W2565985037 hasAuthorship W2565985037A5084863264 @default.
• W2565985037 hasAuthorship W2565985037A5088003995 @default.
• W2565985037 hasAuthorship W2565985037A5091261500 @default.
• W2565985037 hasBestOaLocation W25659850372 @default.
• W2565985037 hasConcept C118487528 @default.
• W2565985037 hasConcept C119767625 @default.
• W2565985037 hasConcept C126322002 @default.
• W2565985037 hasConcept C134018914 @default.
• W2565985037 hasConcept C141071460 @default.
• W2565985037 hasConcept C195910791 @default.

• next